impact factor
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

2012 Vol.30, N°4 - Suppl.73 - Table of contents

Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations

Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations

Guest Editors: G. Turchetti, J.S. Smolen, A. Kavanaugh, J. Braun, T. Pincus

Introduction

CER6155
2012,30,4,Suppl.73
Pg. 0000

Free to view

Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic considerations
G. Turchetti, J.S. Smolen, A. Kavanaugh, J. Braun, T. Pincus

Rheumatology Abstract

Rheumatology Article

 

CER6149
2012,30,4,Suppl.73
Pg. 0001

Free to view

Treat-to-target in rheumatoid arthritis: clinical and pharmacoeconomic considerations. Introduction
G. Turchetti, J.S. Smolen, A. Kavanaugh, J. Braun, T. Pincus, S. Bombardieri

Rheumatology Abstract

Rheumatology Article

A. Clinical considerations

CER5985
2012,30,4,Suppl.73
Pg. 0002-0006

Free to view

Treat-to-target: rationale and strategies
J.S. Smolen

Rheumatology Abstract

Rheumatology Article

 

CER5986
2012,30,4,Suppl.73
Pg. 0007-0009

Free to view

Treat-to-target: measures
Y. Yazici

Rheumatology Abstract

Rheumatology Article

 

CER6031
2012,30,4,Suppl.73
Pg. 0010-0020

Free to view

Treat-to-target: not as simple as it appears
T. Pincus, I. Castrejón, M.J. Bergman, Y. Yazici

Rheumatology Abstract

Rheumatology Article

 

CER5704
2012,30,4,Suppl.73
Pg. 0021-0026

Free to view

Do we need guidelines to stop as well as to start biological therapies for rheumatoid arthritis?
M. Van Den Broek, W. Lems, C. Allaart

Rheumatology Abstract

Rheumatology Article

B. Clinical trials

CER5987
2012,30,4,Suppl.73
Pg. 0027-0031

Free to view

Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis
V. Rantalaiho, K. Puolakka, M. Korpela, P. Hannonen, T. Möttönen

Rheumatology Abstract

Rheumatology Article

 

CER5988
2012,30,4,Suppl.73
Pg. 0032-0034

Free to view

Intensive management of early rheumatoid arthritis: the TICORA and TEAR studies
D. Porter

Rheumatology Abstract

Rheumatology Article

 

CER5706
2012,30,4,Suppl.73
Pg. 0035-0038

Free to view

BeSt practice: the success of early-targeted treatment in rheumatoid arthritis
M. Van Den Broek, W. Lems, C. Allaart

Rheumatology Abstract

Rheumatology Article

 

CER5989
2012,30,4,Suppl.73
Pg. 0039-0043

Free to view

The CAMERA (Computer-Assisted Management in Early Rheumatoid Arthritis) studies
J.W. Jacobs

Rheumatology Abstract

Rheumatology Article

 

CER6000
2012,30,4,Suppl.73
Pg. 0044-0049

Free to view

The CIMESTRA study: intra-articular glucocorticosteroids and synthetic DMARDs in a treat-to-target strategy in early rheumatoid arhtritis
M.L. Hetland, K. Hørslev-Petersen

Rheumatology Abstract

Rheumatology Article

 

CER6026
2012,30,4,Suppl.73
Pg. 0050-0055

Free to view

Patient self-report outcomes to guide a treat-to-target strategy in clinical trials and usual clinical care of rheumatoid arthritis
I. Castrejón, T. Pincus

Rheumatology Abstract

Rheumatology Article

 

CER5990
2012,30,4,Suppl.73
Pg. 0056-0063

Free to view

Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission
M.S. Jurgens, P.M. Welsing, J.W. Jacobs

Rheumatology Abstract

Rheumatology Article

C. Pharmacoeconomic considerations

CER6037
2012,30,4,Suppl.73
Pg. 0064-0071

Free to view

The rationale of pharmacoeconomic analysis in rheumatologic indications
G. Turchetti, L. Scalone, O. Della Casa Alberighi, M. Mosca, S. Montella, P.A. Cortesi, L.G. Mantovani

Rheumatology Abstract

Rheumatology Article

 

CER6033
2012,30,4,Suppl.73
Pg. 0072-0084

Free to view

Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis
G. Furneri, L.G. Mantovani, A. Belisari, M. Mosca, M. Cristiani, S. Bellelli, P.A. Cortesi, G. Turchetti

Rheumatology Abstract

Rheumatology Article

 

CER5991
2012,30,4,Suppl.73
Pg. 0085-0090

Free to view

Payers` views on treating-to-target in rheumatoid arthritis: an English perspective
I.C. Scott, A. Wailoo, D.L. Scott

Rheumatology Abstract

Rheumatology Article

 

CER5995
2012,30,4,Suppl.73
Pg. 0091-0095

Free to view

A clinician`s perspective on pharmacoeconomics and rheumatology
C. Thielscher

Rheumatology Abstract

Rheumatology Article

 

CER5994
2012,30,4,Suppl.73
Pg. 0096-0101

Free to view

Interest of modelling in rheumatoid arthritis
A. Beresniak, D.M. Dupont, J.-C. Becker, S. Merkesdal

Rheumatology Abstract

Rheumatology Article

 

CER5993
2012,30,4,Suppl.73
Pg. 0102-0106

Free to view

Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues
G. Lapadula, G.F. Ferraccioli

Rheumatology Abstract

Rheumatology Article

 

CER5992
2012,30,4,Suppl.73
Pg. 0107-0111

Free to view

Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis
M. Her, A. Kavanaugh

Rheumatology Abstract

Rheumatology Article

D. Specific diseases

CER5996
2012,30,4,Suppl.73
Pg. 0112-0115

Free to view

Treat-to-target in systemic lupus erythematosus: where are we today?
M. Mosca, D.T. Boumpas, I.N. Bruce, R. Cervera, L. Czirjak, T. Dörner, F. Houssiau, S. Jacobsen, M. Schneider, J.S. Smolen, A.E. Voskuyl, R.F. Van Vollenhoven

Rheumatology Abstract

Rheumatology Article

 

CER6034
2012,30,4,Suppl.73
Pg. 0116-0122

Free to view

Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider
G. Turchetti, J. Yazdany, I. Palla, E. Yelin, M. Mosca

Rheumatology Abstract

Rheumatology Article

 

CER5997
2012,30,4,Suppl.73
Pg. 0123-0125

Free to view

Psoriatic arthritis: treat-to-target
A. Kavanaugh

Rheumatology Abstract

Rheumatology Article

 

CER6036
2012,30,4,Suppl.73
Pg. 0126-0131

Free to view

Systematic literature review on economic implications and pharmacoeconomic issues of psoriatic arthritis
P.A. Cortesi, L. Scalone, L. D`angiolella, A. Belisari, F. Fusco, I. Olivieri, L.G. Mantovani

Rheumatology Abstract

Rheumatology Article

 

CER5998
2012,30,4,Suppl.73
Pg. 0132-0135

Free to view

Axial spondyloarthritis: thoughts about nomenclature and treatment targets
J. Braun

Rheumatology Abstract

Rheumatology Article

 

CER6042
2012,30,4,Suppl.73
Pg. 0136-0141

Free to view

A systematic literature review of the economic impact of ankylosing spondylitis
I. Palla, L. Trieste, C. Tani, R. Talarico, P.A. Cortesi, M. Mosca, G. Turchetti

Rheumatology Abstract

Rheumatology Article

 

CER5999
2012,30,4,Suppl.73
Pg. 0142-0144

Free to view

Gout: thoughts about a treat-to-target programme
J. Braun, J.S. Smolen

Rheumatology Abstract

Rheumatology Article

 

CER6043
2012,30,4,Suppl.73
Pg. 0145-0148

Free to view

The economic impact of gout: a systematic literature review
L. Trieste, I. Palla, F. Fusco, C. Tani, C. Baldini, M. Mosca, G. Turchetti

Rheumatology Abstract

Rheumatology Article

 

CER6030
2012,30,4,Suppl.73
Pg. 0149-0153

Free to view

Treat-to-target in vasculitis: is this a sensible approach?
R.A. Luqmani

Rheumatology Abstract

Rheumatology Article

 

CER6044
2012,30,4,Suppl.73
Pg. 0154-0156

Free to view

Systemic vasculitis: how little we know about their societal and economic burden
L. Trieste, I. Palla, C. Baldini, R. Talarico, L. D`angiolella, M. Mosca, G. Turchetti

Rheumatology Abstract

Rheumatology Article

 

CER6014
2012,30,4,Suppl.73
Pg. 0157-0162

Free to view

Toward a treat-to-target approach in the management of juvenile idiopathic arthritis
A. Consolaro, G. Negro, S. Lanni, N. Solari, A. Martini, A. Ravelli

Rheumatology Abstract

Rheumatology Article

Continuing Medical Education Activity

CER6156
2012,30,4,Suppl.73
Pg. 0163-0169

Free to view

Treat-to-target in Rheumatoid Arhritis: CME activity
No Author

Rheumatology Abstract

Rheumatology Article